Biotech companies saw the most notable insider purchases of the past week. A Mexican billionaire also continued to build a stake.
Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback